These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 22990115)
1. Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression. Sun J; Wang Y; Yang J; Du D; Li Z; Wei J; Yang A Exp Mol Med; 2012 Nov; 44(11):674-83. PubMed ID: 22990115 [TBL] [Abstract][Full Text] [Related]
2. Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy. Binley K; Askham Z; Iqball S; Spearman H; Martin L; de Alwis M; Thrasher AJ; Ali RR; Maxwell PH; Kingsman S; Naylor S Blood; 2002 Oct; 100(7):2406-13. PubMed ID: 12239150 [TBL] [Abstract][Full Text] [Related]
3. Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner. Chiang CK; Tanaka T; Inagi R; Fujita T; Nangaku M Lab Invest; 2011 Nov; 91(11):1564-71. PubMed ID: 21863063 [TBL] [Abstract][Full Text] [Related]
4. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Rizzuto G; Cappelletti M; Mennuni C; Wiznerowicz M; DeMartis A; Maione D; Ciliberto G; La Monica N; Fattori E Hum Gene Ther; 2000 Sep; 11(13):1891-900. PubMed ID: 10986561 [TBL] [Abstract][Full Text] [Related]
5. Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure. Ataka K; Maruyama H; Neichi T; Miyazaki J; Gejyo F Am J Nephrol; 2003; 23(5):315-23. PubMed ID: 12915775 [TBL] [Abstract][Full Text] [Related]
6. Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene. Oh TK; Quan GH; Kim HY; Park F; Kim ST Am J Nephrol; 2006; 26(4):326-34. PubMed ID: 16825758 [TBL] [Abstract][Full Text] [Related]
7. Therapy of anemia in kidney failure, using plasmid encoding erythropoietin. Richard-Fiardo P; Payen E; Chèvre R; Zuber J; Letrou-Bonneval E; Beuzard Y; Pitard B Hum Gene Ther; 2008 Apr; 19(4):331-42. PubMed ID: 18341422 [TBL] [Abstract][Full Text] [Related]
8. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Tripathy SK; Svensson EC; Black HB; Goldwasser E; Margalith M; Hobart PM; Leiden JM Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10876-80. PubMed ID: 8855275 [TBL] [Abstract][Full Text] [Related]
9. The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1. Galson DL; Tsuchiya T; Tendler DS; Huang LE; Ren Y; Ogura T; Bunn HF Mol Cell Biol; 1995 Apr; 15(4):2135-44. PubMed ID: 7891708 [TBL] [Abstract][Full Text] [Related]
10. Ligand-regulatable erythropoietin production by plasmid injection and in vivo electroporation. Terada Y; Tanaka H; Okado T; Shimamura H; Inoshita S; Kuwahara M; Akiba T; Sasaki S Kidney Int; 2002 Dec; 62(6):1966-76. PubMed ID: 12427121 [TBL] [Abstract][Full Text] [Related]
11. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury. Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192 [TBL] [Abstract][Full Text] [Related]
12. Efficient and ligand-dependent regulated erythropoietin production by naked dna injection and in vivo electroporation. Terada Y; Tanaka H; Okado T; Inoshita S; Kuwahara M; Akiba T; Sasaki S; Marumo F Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S50-3. PubMed ID: 11576922 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes. Shibata T; Akiyama N; Noda M; Sasai K; Hiraoka M Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):913-6. PubMed ID: 9845121 [TBL] [Abstract][Full Text] [Related]
14. A new biological strategy for high productivity of recombinant proteins in animal cells by the use of hypoxia-response enhancer. Masuda S; Moon SK; Kambe T; Nagao M; Sasaki R Biotechnol Bioeng; 2000 Jan; 67(2):157-64. PubMed ID: 10592513 [TBL] [Abstract][Full Text] [Related]
15. Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats. Maruyama H; Ataka K; Gejyo F; Higuchi N; Ito Y; Hirahara H; Imazeki I; Hirata M; Ichikawa F; Neichi T; Kikuchi H; Sugawa M; Miyazaki J Gene Ther; 2001 Mar; 8(6):461-8. PubMed ID: 11313825 [TBL] [Abstract][Full Text] [Related]
16. Generation of transgenic fibroblasts producing doxycycline-inducible human interferon-α or erythropoietin for a bovine mammary bioreactor. Kang HY; Hong EJ; Hwang KC; Kim NH; Hwang WS; Jeung EB Mol Med Rep; 2015 Jul; 12(1):1137-44. PubMed ID: 25779628 [TBL] [Abstract][Full Text] [Related]
17. Progress toward a nonviral gene therapy protocol for the treatment of anemia. Sebestyén MG; Hegge JO; Noble MA; Lewis DL; Herweijer H; Wolff JA Hum Gene Ther; 2007 Mar; 18(3):269-85. PubMed ID: 17376007 [TBL] [Abstract][Full Text] [Related]
18. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Svensson EC; Black HB; Dugger DL; Tripathy SK; Goldwasser E; Hao Z; Chu L; Leiden JM Hum Gene Ther; 1997 Oct; 8(15):1797-806. PubMed ID: 9358029 [TBL] [Abstract][Full Text] [Related]
19. Co-transactivation of the 3' erythropoietin hypoxia inducible enhancer by the HIF-1 protein. Varma S; Cohen HJ Blood Cells Mol Dis; 1997 Aug; 23(2):169-76. PubMed ID: 9236155 [TBL] [Abstract][Full Text] [Related]
20. Rabbit EPO gene and cDNA: expression of rabbit EPO after intramuscular injection of pDNA. Vilalta A; Wu D; Margalith M; Hobart P Biochem Biophys Res Commun; 2001 Jun; 284(3):823-7. PubMed ID: 11396976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]